Average Co-Inventor Count = 8.00
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Fulcrum Therapeutics, Inc. (7 from 8 patents)
7 patents:
1. 12109198 - Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
2. 11590111 - Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
3. 11479770 - Use of p38 inhibitors to reduce expression of DUX4
4. 11291659 - P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
5. 10973805 - Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
6. 10537560 - P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
7. 10342786 - P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD